The FDA has approved Lundbeck’s Carnexiv, also known as carbamazepine, as a short-term (≤7 days) intravenous replacement treatment for adults with certain seizure types who cannot take the oral form of carbamazepine.
The FDA has approved Lundbeck’s Carnexiv, also known as carbamazepine, as a short-term (≤7 days) intravenous replacement treatment for adults with certain seizure types who cannot take the oral form of carbamazepine.